Negative FILIP1L expression was independently associated with poor overall survival after adjustment for several covariates, such as age, sex, tumor size, lymphovascular invasion, perineural invasion, and cancer stage (HR: 1.62; 95% CI: 1.07–2.46; P = 0.023; Table 2). Here, FILIP1L is linked to cancer.